Multi-criteria decision making of COVID-19 vaccines (in India) based on ranking interpreter technique under single valued bipolar neutrosophic environment

COVID-19 is a respiratory infection caused by a coronavirus that spreads from person to person. In the present situation, the COVID-19 pandemic is a swiftly rising phase. Now the time is the second wave ending phase of coronavirus and the third wave coming phase of coronavirus in India. The pandemic situation is moving forward all over India. Nowadays, the worldwide COVID-19 pandemic structure is a very hazardous situation. The COVID-19 vaccine can suppress this situation and gain preventive measures against coronavirus. In producing the COVID-19 vaccine, the Indian medical board plays a significant role. The COVID-19 vaccines have exhibited 90%-95% efficacy in preventing symptomatic COVID-19 infections. Against COVID-19, for emergency purposes, the Indian medical board has approved three vaccines: Covishield, Covaxin, and Sputnik V. Generally, the Indian people are embarrassed about the vaccination of COVID-19. All people are thinking about which vaccine is best for them. This labyrinth can be evaluated effectively using the multi-criteria decision-making (MCDM) technique. Therefore, we have proposed a novel MCDM technique for selecting COVID-19 vaccines. The main aim of this paper is to develop an MCDM technique based on a lambda -weighted ranking interpreter ( R lambda+ , R-lambda). The first time, we have defined positive and negative lambda-weighted rank interpreter for the ranking of single-valued bipolar neutrosophic (SVbN) number. Additionally, positive and negative lambda-weighted values and positive and negative lambda-weighted ambiguity of an SVbN-number are formulated here. Some important, valuable theorems and corollary of SVbN-number are formulated. To show the applicability of the proposed MCDM technique, we have considered a real decision-making problem where ratings of the alternatives are with SVbN-numbers.